<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02829788</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL16_0433</org_study_id>
    <nct_id>NCT02829788</nct_id>
  </id_info>
  <brief_title>Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic Approach</brief_title>
  <acronym>COELIOCHIP</acronym>
  <official_title>Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The peritoneum is the second most common site of recurrence in patients with colorectal
      cancer. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy improve the
      prognosis of these patients and incorporates surgical removal of all visible disease followed
      by chemical destruction of microscopic disease through chemoperfusion. The most validated
      predictors of outcome are preoperative tumor burden measured in terms of the peritoneal
      carcinomatosis index (PCI) and completeness of cytoreduction (CC score). Diagnostic
      laparoscopy prior to resection is widely used in hepatopancreaticobiliary and colorectal
      cancer and has been shown to be effective in excluding unnecessary laparotomy associated with
      higher morbidity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peritoneal carcinomatosis staging</measure>
    <time_frame>during laparoscopy and during laparotomy (Day 1)</time_frame>
    <description>To score the Collect detailed detailed Peritoneal Cancer Index (PCI) by laparoscopy following the laparotomy procedure in order to evaluate the accuracy and adequacy of laparoscopic surgical staging comparing to laparotomic approach.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Colorectal Peritoneal Carcinomatosis</condition>
  <arm_group>
    <arm_group_label>Digestive peritoneal carcinomatosis staging</arm_group_label>
    <description>All patients underwent laparoscopic followed by laparotomic surgical staging.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non interventional</intervention_name>
    <description>Peroperative data collection</description>
    <arm_group_label>Digestive peritoneal carcinomatosis staging</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Prospectively diagnosed patients initially treated with surgery and adjuvant chemotherapy
        who have a high risk of developing colorectal peritoneal carcinomatosis.

        All patients will receive the current standard adjuvant treatment: 6 months of systemic
        chemotherapy (currently the Folfox-4 regimen which could be modified if the standard is
        modified). Then a work-up is done to exclude recurrence.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Colorectal cancer with a resected minimal synchronous peritoneal
             carcinomatosis, or ovarian metastases, tumour rupture in the abdominal cavity.

          -  Patients received six months of systemic chemotherapy (currently the Folfox-4 regimen
             which could be modified if the standard is modified)

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier GLEHEN, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet, PIERRE-BENITE, FRANCE, 69495</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier GLEHEN, Prof</last_name>
    <phone>(0)4 78 862 371</phone>
    <phone_ext>+33</phone_ext>
    <email>olivier.glehen@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peggy JOURDAN-ENFER</last_name>
    <phone>(0)4 78 864 534</phone>
    <phone_ext>+33</phone_ext>
    <email>peggy.jourdan-enfer@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Centre Hospitalier Lyon Sud Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet</name>
      <address>
        <city>Pierre-benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier GLEHEN, Prof</last_name>
      <phone>(0)4 78 862 371</phone>
      <phone_ext>+33</phone_ext>
      <email>olivier.glehen@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Peggy JOURDAN-ENFER</last_name>
      <phone>(0)4 78 864 534</phone>
      <phone_ext>+33</phone_ext>
      <email>peggy.jourdan-enfer@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2016</study_first_submitted>
  <study_first_submitted_qc>July 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2016</study_first_posted>
  <last_update_submitted>July 11, 2016</last_update_submitted>
  <last_update_submitted_qc>July 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Digestive peritoneal carcinomatosis</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>laparotomy</keyword>
  <keyword>peritoneal cancer index (PCI)</keyword>
  <keyword>staging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

